A Phase Ib Study of GB491 Plus Letrozole in Patients With Advanced Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Advanced Breast Cancer
Interventions: DRUG: GB491+Letrozole
Sponsor: Genor Biopharma Co., Ltd.